A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Virtual health: Extending the Military Health System’s outreach and reach-back

by Bruce Green, Managing Director, Chief Medical Officer, Deloitte Consulting LLP

As the functional manager of the US Air Force Medical Service and the 20th Air Force Surgeon General, I saw first-hand how digital technologies can extend the outreach and reach-back of the Military Health System (MHS) to improve operating efficiency and the patient experience. One technology which is already demonstrating its value, and which holds even greater promise for the future,

Read more

Could changes to funding streams put biomedical innovation at risk?

by Margaret Anderson, Managing Director, Deloitte Consulting LLP

Funding and other support from private organizations and philanthropists has helped keep many medical researchers at the forefront of their fields, which has resulted in some cases in longer life expectancies and a higher quality of life for people affected by certain diseases. To help ensure science funding pipelines continue to be robust—and to help train the next generation of researchers—nonprofit biomedical funding organizations should pay close attention to the changing nature of giving.

Read more

Consumers want connected medical devices, but demand for digital experts could put further strains on the talent pool for medtech

by Pedro Arboleda, Managing Director, Deloitte Monitor

This week, my colleagues and I are attending AdvaMed’s annual MedTech Conference. Participants will hear about the latest innovations, such as new digital products that incorporate the latest advances in wireless technology and increasingly powerful computing capabilities for generating clinical and economic insights. But I worry the industry might overlook another important change that is occurring in parallel—the ability to attract the specific digital talent needed to deliver on the promise of connected medical devices.

Read more

Medtech companies can add value by uprooting low-value care

by Glenn Snyder, Principal, MedTech Practice Leader, Deloitte Consulting LLP

I’m headed to Philadelphia next week to moderate a panel of medtech CEOs at AdvaMed’s annual conference. Our topic: strategies to reduce low-value care. This is an important issue not just for medtech leaders, but for all health care stakeholders. The cost of low-value care is staggering. In the US alone, medical services that don’t necessarily benefit the patient top $200 billion annually.1

What is low-value care?

Read more

How a digital R&D strategy can improve clinical trial innovation and execution

by Dawn Anderson, Managing director, Deloitte Consulting LLP

The Deloitte Center for Health Solutions recently interviewed 43 biopharmaceutical industry stakeholders to explore where the industry sees value and opportunities for using digital technologies in the clinical development process; understand reasons behind the relatively slow pace of digital adoption; and uncover strategies to overcome barriers and accelerate the use of digital in clinical trials.

Read more

Real-world evidence is helping some biopharma companies develop therapies for peanut allergies

by Steve Davis, Deloitte Center for Health Solutions

On July 11, my 10-year-old son ate a peanut. This is hardly a noteworthy event for most kids, but it could be life-changing for him. Unlike the other times Ian has eaten something that contained peanut, this time we weren’t fumbling for an epinephrine auto-injector while speeding to the emergency room. Instead, we sat calmly in our allergist’s office and watched cartoons.

Read more